Chuck Spencer, MD, FAAP
t is 2002 and where is pediatric rheumatology 6) The Pediatric Rheumatology Online Journal
Section on (PR) going? It does depend on your local (PROJ), an international endeavor, is in develop-
Rheumatology perspective – how busy you are, how’s the ment and the first online issue will be available
research going, how is the budget, how friendly is this fall.
Spring 2002 your chair, do you need another person in the
section, how is the home life? So, I believe pediatric rheumatology has made some
important progress in the past two years. We have
But optimist/pessimist that I am (expect the worst, much more to do. You may have already heard these
hope for the best), I see some favorable signs for ideas, however, they are worth repeating.
our subspecialty in the US and around the world.
1) More cooperation and less competition between
1) Pediatric rheumatology, more than most US pediatric rheumatology centers.
pediatric subspecialties, is truly international.
Our numbers are not large in any one country 2) Make the PRRN work and make it inclusive,
Section on Rheumatology News
AMERICAN ACADEMY OF PEDIATRICS
and so worldwide we need each other in involving most, if not all US centers.
many ways. Now it does depend on your
definition of pediatric rheumatologist, but 3) Limited tolerance for territoriality and competi-
there may well be as many as 225 pediatric tiveness between PR centers, national and
rheumatologists in the United States (board international – cooperation benefits everyone.
certified or not), 30 in Canada, 340 in
PRINTO, 250 Europeans not in PRINTO, 20 in 4) Do our best to excite medical students about
Asia, and other PR unknown to us in India pediatric rheumatology- there is some evidence
and other countries (800 – 1000 total). You in the US (AAP 3rd Year Resident Survey) that a
are not alone. substantial number of senior students who have
decided on pediatrics and entering first year
2) Cooperation and collaboration between pediatric residents have already formed an
centers in the US and international coopera- opinion about their career choice of general
tion appears to be improving. PRCSG and pediatrics versus pediatric subspecialties and
PRINTO are more linked than ever, although, even have decided which pediatric subspecialty.
much work still needs to be done. The US Furthermore, we should work to get senior
Pediatric Rheumatology Research Network students on our elective rotations.
(PRRN) is maturing, though again, not past
its infancy. 5) Train more pediatric rheumatology fellows. We
need 400 pediatric rheumatologists in the US
3) Drug trials in the US, Canada, and Europe and no doubt many PR’s in Canada, Latin
are dramatically increasing. Not only do America, Europe, and Asia.
these trials have the potential to provide
our kids with new and better drugs, but these
trials may help financially support our continued on page 4
centers as well.
4) More pediatric residents in the US are going
into pediatric subspecialities in 2002, INSIDE THIS ISSUE
currently there are 38 fellows in pediatric
rheumatology. It is our job to recruit more
Mentorship Survey 2
into the field of PR.
CME Course Update 3
5) The American College of Rheumatology, the
American Juvenile Arthritis Organization, and
Upcoming Meetings and Events 5
the AAP will sign a Memorandum of Under-
Executive Summary 8
standing for pediatric rheumatology at the
ACR’s Annual Meeting in October 2002. The
memorandum documents the intention of all
three organization’s to work together and
advocate for children with rheumatic disease
and for pediatric rheumatology in the US.
MENTOR/MENTEE REQUEST FORM
Please FAX to Laura Laskosz at 847/434-8000 by July 1, 2002
We need more quality mentoring in pediatric rheumatology!! If you are interested in becoming a
mentor or a mentee, please complete the form below and fax it to Laura Laskosz at 847/434-8000.
I REQUEST TO BE A: MENTOR _______ MENTEE _______
I AM INTERESTED IN ATTENDING A SEMINAR ON MENTORSHIP: YES _________
Email address: ______________________________________________________________________
Telephone # ________________________ FAX # ____________________________
My idea for topic(s) to be covered in a mentorship seminar are:
Barbara Ostrov, MD
The AJAO meeting took place on April 16, The AJAO Web site was discussed improving access to Pediatric
2001 in Atlanta. several times. It now contains updated Rheumatologists and funding fellow-
“brochure” information on juvenile ships in Pediatric Rheumatology.
Several items were discussed. dermatomyositis. Pediatric lupus, JRA and
spondyloarthropathy updates should be The AJAO Conferences were discussed
Delta Airlines has an exciting program on-line soon. The address is: in detail as well. This summer, there will
called “Delta Sky Miles” in which any www.arthritis.org. There is an immediate be a national conference in Minnesota.
person or organization can donate their link to the “Juvenile arthritis” section right In the summer of 2003, there will be two
frequent flyer miles to the AJAO. These on the home page. Everyone is encour- large regional meetings, one on the east
miles can be used to send families to the aged to check it out and give their coast and one near the west coast as
national conference or to help volunteers comments. well as five “Family Days” scattered
attend meetings and activities. This around the country. Financial support
program lasts for 3 months and is There was a long discussion about the will come from the AF as part of the
promoted on the AF web site, as well as proposed “Primer of Pediatric Rheumatic AJAO budget. The goal of these day-
Delta’s web site. Diseases.” There is strong support for long programs is to garner participation
development of this book. A detailed from pediatric rheumatology centers/
The AJAO Board has wanted to update prospectus was developed and financial practices that usually do not run such
the physician referral list that we pub- backing is the next step in production of activities. The goal is to develop
lished about 4-5 years ago. It was this project. programs in a variety of local communi-
decided that rather than re-create a list, ties, reaching populations that are often
we would instead add this information to The Board was appraised of the newly missed by the size, scope and cost of
our AJAO web site with links to the AAP formed Pediatric Rheumatology Research the larger AJAO meetings.
and ACR pediatric rheumatologists’ Network (PRRN) and strongly supports its
listings. Several board members designed efforts. The AJAO has pledged to raise The next board meeting will be in
the web page to clarify the important $250,000 this year to support Pediatric Minnesota in July.
issues at hand for individuals seeking Rheumatology initiatives, including
AAP Section on Rheumatology Newsletter 2
Pediatric Rheumatology 2003: Park City and Beyond
Norm Ilowite and Ron Laxer, Course Co-Chairs
n March 1976, a small number of clinicians gathered in Park Snowmass is the site of the American College of Rheumatology’s
City, Utah under the auspices of the ARA (currently ACR) to Annual Winter Meeting and has a reputation as an outstanding
discuss the newly developing specialty of pediatric rheuma- meeting venue. In addition to the convention center, just a few
tology. In fact, the specialty of pediatric rheumatology was short steps away, the Silvertree Hotel will also house the posters
legitimized at Park City through the publication of a supplement and break out sessions. Other hotels and condominiums in our
to Arthritis and Rheumatism, which was the first collection of “block” are also very close to the convention center. Snowmass
work, devoted exclusively to the rheumatic diseases of child- is one of 4 ski mountains in the Aspen/Snowmass area, and a lift
hood. All of us in pediatric rheumatology, as well as our patients ticket for one is good at all 4, which are accessible via a free
and their families, owe a tremendous debt of gratitude to these intermountain shuttle. Reduced prices for ski-lift tickets will be
pioneers in the field. Subsequent Park City meetings were held made available for meeting registrants. The convention center and
in 1986, 1991 and 1998, and each grew in numbers, content and lodging sites provide for nearly ski-on ski-off accessibility, making
international representation. The success of these meetings has the combining of recreational and scientific activities more
been such that we have now outgrown the Park City facilities! efficient. For non-downhill skiers, snowshoeing, sledding, ice
skating, snow-mobiling, dogsledding, horse-drawn carriage tours,
The fifth “Park City” meeting will be held from March 22-26, horse drawn sleighrides, and cross-country skiing make this area
2003. In keeping with the tradition of combining a high-level an internationally renowned winter wonderland. Additionally, the
academic program with fun on the slopes, a return to a ski venue shopping, art galleries and culinary attractions of Aspen are
was decided. Working with the American Academy of Pediat- incomparable.
rics, Snowmass, Colorado was identified as the best location in
terms of ability to accommodate the number of expected Registration forms for the meeting will be mailed in September
registrants, quality of resort, quality of skiing and other recre- 2002. Please register early and make sure to reserve your hotel
ational activities, and accessibility. The Rheumatology Section accommodations, as they are sure to be taken quickly. Reduced
of the AAP is sponsoring the meeting and the Section and AAP airfares will be made available through the American Academy of
staff have both been integral in its planning, a great deal of Pediatrics Travel office.
which has already occurred. The Organizing Committee (see
membership below) has developed a wonderful scientific So, please stay tuned for further information. Feel free to contact
program. An international list of “who’s who” will present any member of the Organizing Committee for additional informa-
didactic plenary sessions each morning. These will be followed tion.
by concurrent sessions covering a wide range of topics includ-
ing basic science, epidemiology, health outcomes and clinical ORGANIZING COMMITTEE
problem solving. New for this meeting will be a series of “Meet Norm Ilowite, Ron Laxer (co-chairs)
the Expert” sessions which are intended to be optional, in order Bob Colbert, Peter Malleson, Dan Lovell, Sue Bowyer, Barry
to provide small group interaction, requested in numerous Myones, Carol Lindsley (ACR Representative), Egla Rabinovich,
evaluations of past meetings. As in the past, “apres-ski” poster Rob Sundel, Terri Finkel, Susan Wright (ARHP representative),
sessions will be presented. The format is such that the plenary Chuck Spencer (AAP Representative)
sessions will largely be from 7-8:45 AM, concurrent sessions International Representatives:
from 9:15-10:15AM and repeated from 6-7PM, and posters from Pat Woo, Angelo Ravelli
4-6PM. The Meet the Expert sessions will be held from 10:30-
11:30 AM. This will allow full day skiing if desired, as well as
equal or greater educational and scientific content as compared
to previous Park City meetings.
AAP Grand Rounds
The Scientific Committee, chaired by Bob Colbert, will be
responsible for abstract selection and determination of abstract Susan Ballinger, MD, FAAP, a member of the Section
award winners. The ARHP program chair is Suzanne Wright, on Rheumatology is now a Contributing Editor for
and this program will have both unique and shared sessions Rheumatology for the AAP Grand Rounds. She
with the general program. Special sessions for trainees are welcomes input from section members regarding
planned. Proceedings and abstracts will be published in the recent articles that you think may
Journal of Rheumatology. be useful for section members
and/or all AAP members to be
A Banquet will be held on March 25th during which we will aware of. Please submit your
recognize colleagues who have made, and continue to make, recommendations to Dr Ballinger at
extraordinary contributions to our field. firstname.lastname@example.org.
AAP Section on Rheumatology Newsletter 3
continued from page 1
Daniel Lovell, MD
6) Seek funding from pharmaceutical articipation in clinical trials is the COX-2 studies, the infliximab, the
companies to provide debt relief to continuing to grow among the anakinra and the D2E7 studies are actively
pediatric rheumatology fellows in the members of the Pediatric Rheumatol- seeking additional centers to participate. If
next ten years. ogy Collaborative Study Group (PRCSG). you have an interest in participating in
. Many sites are currently participating in one or more of these studies then please
7) Train more pediatric rheumatologists one of two COX-2 trials, with a third trial to contact Daniel Lovell or Edward Giannini
as clinical and basic scientists. Our start this summer. The PRCSG and the at 513-636-7686. A NIH sponsored
kids will not do well without better Pediatric Rheumatology International randomized intervention trial for new
science and we cannot advance as a Trials Organization (PRINTO), headquar- onset JDM will begin this summer with 11
subspecialty without better science. tered in Europe, are continuing to collect centers participating.
information about long-term safety of
8) Seek more support from academic cyclosporin. This worldwide database is In addition to pharmaceutical studies,
pediatric administrations and Chairs the largest and the longest follow-up there are a number of ongoing studies to
for the PR niche. We need a minimum safety study ever done on cyclosporin. develop and validate definitions used by
of five pediatric rheumatologists (3 pediatric rheumatologists. The PRCSG and
clinical, 2 research) at the 20+ major New advances in anti-TNF and monoclonal PRINTO are evaluating core set definitions
PR centers in the US by 2020. Good antibody therapy have provided many new of disease activity and damage for children
luck you say. It will not be easy and treatments that should be considered as with JDM and JSLE. Carol Wallace and Ed
may even be impossible, but I believe additions to our arsenal for defense Giannini have been working with PRCSG,
that it is our responsibility to work against JRA. However, to do so in an PRINTO and ACR members in a project to
persistently and stubbornly to informed fashion requires the performance define “complete clinical response” and
develop our centers, even in times of of trials in children with JRA. Currently, “remission” in JRA patients. The JRA core
Medicaid cuts and bottom line there are three studies evaluating set and definition of improvement have
administrators. etanercept. One is an ongoing open been approved by the ACR and in the near
treatment follow-up study of those who future will be called the “ACR Pediatric
9) Raise money for pediatric rheumatol- participated in the blinded efficacy study. 30”.
ogy centers from private donors- Another is a large registry study to assess Members of the PRCSG Coordinating
several centers do it well, but more of safety comparing JRA patients treated with Center and Advisory Council continue to
us should give it a try. methotrexate, etanercept and the combina- be actively involved in the work to
tion of etanercept and methotrexate. The develop the Pediatric Rheumatology
This is a challenging time for our subspe- last is a study of the safety and efficacy of Research Network (PRRN). The PRRN
cialty but also a time of great promise and etanercept in systemically active Systemic has, as it’s ultimate goal, to develop a
potential. With hard work and some good JRA patients. There is a study evaluating network of pediatric rheumatologists with
luck, we can achieve some of these goals infliximab given concomitantly with MTX, support for infrastructure to facilitate the
by 2010 and many by 2020. one study evaluating anti-IL-1 RA performance of high quality research in a
(anakinra), and one study evaluating variety of pediatric rheumatic illnesses.
adalimumab (D2E7). The D2E7 study is The emphasis of the PRRN will be on
scheduled to begin this summer. Some of investigator initiated research.
At the next American College of Rheumatology meeting there will be a
session on osteoporosis and bisphosphonates in children. Treatment
with bisphosphonates in childhood is relatively new, and many aspects
Pediatric Rheumatology are still controversial. Therefore, it would be interesting and useful to
Online Journal know how many people are currently using these drugs for pediatric
rheumatic diseases. If you are treating, or have treated rheumatic
First issue October 2002 patients aged less than 18 years with any of the bisphosphonates, and
would like to participate in this survey, please contact Rolando Cimaz,
visit us in October at:
MD via e-mail at: Rolando.Cimaz@unimi.it.
AAP Section on Rheumatology Newsletter 4
Upcoming Meetings and Events Arthritis Affected Sib-
pair (JRA-ASP) Registry
American Academy of Pediatrics
National Conference and Exhibition
his registry is located at
October 19 – 23, 2002 Children’s Hospital Medical
Center in Cincinnati and spon-
Section on Rheumatology sponsored events sored by the National Institute of
Arthritis and Musculoskeletal and Skin
Monday, October 21, 2002 Diseases (NIAMS) of the National
Institute of Health (NIH). The registry
3:45 - 5:45pm Workshop: Rheumatology for the Primary Care
enrolls families with two or more children
Physician diagnosed with JRA according the ACR
criteria, from the US and Canada. We
Tuesday, October 22, 2001 have 162 families enrolled in the JRA
6:45 - 7:45am Meet the Expert: Rheumatology for the General Affected Sib-pair Registry, as of March
Pediatrician 2002, thanks to the effort of the partici-
9:30 - 11:30am Workshop: Rheumatology for the Primary Care pating families and their physicians. Our
Physician goal is to collect 200 ASP families. The
main aim of the registry is to make
available to the scientific community this
large, unique population of JRA families.
American College of Rheumatology DNA samples are available for the
66th Annual Scientific Meeting majority of registry participants. Investi-
October 25-29, 2002 gators interested in working with this
population can contact the registry
New Orleans, LA manager by phone (513 636-7389) or e-
Saturday, October 26, 2002 mail (email@example.com) for
further information or to obtain a project
4:00 - 5:30pm Treatment of the Refractory Child with
Sunday, October 27, 2002 Registration process:
2:15 - 3:45pm Juvenile Spondyloarthropathies: Bench to Bedside After a physician identifies a family that
2:15 - 3:45pm Rehabilitation of the Child with a Rheumatic qualifies for the registry, he/she obtains
Disease. Combined Conference sponsored by the their permission to inform the registry.
Sections of Pediatrics, Rehabilitation, and the Enrollment requires the following
Association of Rheumatology Health Professionals documentation:
Monday. October 28, 2002
4:00 - 5:00pm Biphosphonates in Children 1. Completed consent from the family
to indicate willingness to participate
in the registry.
2. A questionnaire from the family
regarding medical history of the JRA
Upcoming Events affected members.
3. A questionnaire that is completed by
EULAR 2002 American Academy of Pediatrics the physician.
European Congress of Rheumatology National Conference and
June 12 - 15, 2002 Exhibition Strict confidentiality is maintained by
Stockholm, Sweden October 19-23, 2002 limiting access to the registry database,
Boston, MA the use of passwords and providing
PANLAR unique numeric identifiers for study
8th Annual Panlar Congress American College of Rheumatology participants.
June 23 - 27, 2002 66th Annual Meeting
Aruba October 25 - 29, 2002 David Glass, MD; Principal Investigator
New Orleans, LA Marta Moroldo, MD; Registry Manager
Edith Shear, Study Coordinator
AAP Section on Rheumatology Newsletter 5
Report on Career Workship Executive Committee
November 2001 2001 - 2002
n November 13, 2001, our Section shape a career, as well as the expectations
presented the third in a series of of his co-workers, as a pediatric rheuma- Charles H. Spencer, MD
workshops dealing with career tologist practicing within the context of a
development issues for our membership. general pediatric private practice group. He Executive Committee:
This year’s topic was titled “The Devel- has been able to provide his subspecialty Michael Henrickson, MD
opmental Process for the Pediatric consultative and ongoing care to children James Jarvis, MD
Rheumatologist: Career Paths and with rheumatologic disease, while addi- Barbara Ostrov, MD
Options.” The goal of the workshop was tionally seeing children with other special Murray H. Passo, MD
to demonstrate the options available to us needs, and a “well-kid” population. He has Kenneth Schikler, MD
as our own situations and needs might also been able to interact with a pediatric Robert Sundel, MD
change as our professional careers residency training program, incorporating Past Chairperson:
blossom and mature. Recognizing that all the aspects of a career that he recog- James Cassidy, MD
our own lives continue in a developmen- nized were important to him.
tal fashion, the introductory statements SUBCOMMITTEES:
regarding the stage of “middlessence” Carolyn Yancey, unfortunately was not Outcomes Coordinator:
were presented by Ken Schikler. This was able to be at the workshop, prepared and Lori Tucker, MD
an overview that dealt with the physical sent on to us an elegant presentation of Newsletter Editors:
and psychosocial the options she Thomas J.A. Lehman, MD
changes that has recognized Charles Spencer, MD
progress parallel to and developed for Program Chairperson:
our professional Kenneth Schikler, MD herself in the area Murray Passo, MD
growth, and might Helen Emery, MD of health care Nominations Committee:
influence what David Glass, MD industry. She James Cassidy, MD
goals we wish to Harry Gewanter, MD outlined the Marisa Klein-Gitelman, MD
attain as compared Carolyn Yancey, MD variety of venues Kathleen O’Neil, MD
to what goals we Presented Career Options at the available to the David Siegel, MD
might have set for Workshop, “The Developmental pediatric rheuma-
ourselves when we tologist, from
Process for the Pediatric Barbara Ostrov, MD
left training health policy
Rheumatologist: Career Paths AAP Grand Rounds,
programs. Follow- planning, to health
and Options” Contributing Editor
ing this several of insurance, to
Susan Ballinger, MD
our members pharmaceutical
provided insights development, to
Kenneth Schikler, MD
into how their careers evolved, followed governmental oversight roles that could
Web Site Editor:
by David Glass, who as a mentor to many both challenge one’s clinical skills, and
Thomas J.A. Lehman, MD
of our colleagues shared how he has been have a very meaningful effect on the
able to recognize individuals potential population of children with rheumatologic
Laura Laskosz, MPH
strengths and aid in their decision making conditions. In her distributed material she
regarding career development. pointed out a recurring theme in all the
presentations. Our careers can be as
American College of
Helen Emery shared with us how her plastic or as rigid as we find comfortable or
migration to the U.S., found her becoming necessary, and with creative effort we
Carol Lindsley, MD
a rather permanent (for which we are should be confident in our ability to mold
grateful) resident here, but also found her them as best meets the developmental
taking her role from fellow to attending, to needs that unfold.
chief of Rheumatology service at a new Statements and opinions
and distant medical center after having expressed in this publication
established a clear cut niche at another Visit us on the are those of the authors and
Web! not necessarily those of the
American Academy of Pediatrics
Harry Gewanter, our next presenter, told www.aap.org/sections/
us how his recognition of what he
enjoyed most about the practice of
medicine, guided him in being able to
AAP Section on Rheumatology Newsletter 6
What is the Section Why should I be member of the
working on ? American Academy of Pediatrics?
n Advocacy - including reauthorization Advocacy - The AAP advocates effectively for all children at state and federal levels.
of the Pediatric Studies Provision in The AAP has an excellent Department of Federal Affairs office in Washington that
the Best Pharmaceuticals for Children works for children and teenagers. The Academy is viewed as the “white hat” and has
Act (BPCA). considerable influence. Recent issues include strengthening Medicaid and SCHIP,
youth violence, adolescent health care, tobacco and alcohol advertising, immunizations,
n Initiating a colloborative agreement child abuse, asthma, and birth defects.
between the Section, the ACR, and the
AJAO. More than any other medical organization, the AAP advocates for children and teens
with chronic diseases.
At the federal level in Washington, DC:
n Sponsor several education programs 1) Lobbied extensively for the reauthorization of the IDEA legislation (signed 6/4/97)
at the AAP National Conference and and is monitoring the current reapproval process. Our own section member, Harry
Exhibition. Gewanter, has played an important role in this work.
2) Strongly supported the managed care legislation (managed care patient bill of
n Sponsored Park City IV in 1998 and rights) in Congress, particularly the provision for access to pediatric specialists.
sponsoring Pediatric Rheumatology 3) Consults with congress and the Social Security Administration on SSI issues
2003: Park City and Beyond. 4) Places the highest priority on achieving universal health care for all children. In the
meantime, the AAP supports more steps such as the Families Opportunity Act of 2001.
n Analyzing a survey on women in This Senate legislation would allow families to buy into Medicaid to fill in gaps in their
pediatric rheumatology. insurance and thereby broaden coverage for children with disabilities.
5) Filed a letter of complaint to HCFA for inadequate funding of Medicaid. HCFA has
n Establishing a mentoring program asked State Medicaid Offices to prepare a response.
6) AAP Chapters are working to increase Medicaid reimbursement in most states.
n Proposal for three new programs
including a two - day pediatric The AAP can act quickly: A proposed legislation in early 2000 presented new
rheumatology fellows retreat, funding barriers to obtaining approval of new pediatric oncology drugs. On February
for two research fellowships, and a 25, 2001, the AAP chaired a meeting of national pediatric oncology leaders
debt interest program. and child advocates. The FDA responded by sending a letter to all involved
drug companies asking them to submit fast track approval applications for
these drugs and now these new drugs being tested.
n Established a section web site
including fellowship, job, and other Education
listings. As a member of the Section on Rheumatology, you may be asked to teach
general pediatricians and residents at the national and local level, i.e.: Na-
n Offer three Section-sponsored awards: tional Conference and Exhibition, CME Courses, and State Chapter work-
James T. Cassidy Award, Earl J. Brewer shops. You receive discounts on and access to educational resources of the
Research grant, and Visiting Professor Academy - Pediatrics, PREP, AAP News, Section on Rheumatology newsletter
Program. and web site, and coding manuals.
n In the process of develooping a public The AAP is a unique organization and a significant value for the membership
education brochure, “What is a cost. In no other organiztion can the pediatric rheumatologist interact with
Pediatric Rheumatologist?” other pediatric subspecialists, many of whom are experiencing the same
problems that we face.
n Spearheaded an effort within the AAP
Council on Sections to highlight the We believe that each pediatric rheumatologist and pediatrician with a special
deficiencies in the Summary of the interest in the field should support that Academy and the Section on
Future of Pediatric Education (II) Rheumatology - If you are already a Section member, please keep supporting
report and its lack of support for us, if not, please join us!
subspecialties. This lead to a Com-
mentary article published in Pediatrics Annual Section dues - AAP Fellows $25 Residents $10
in May 2001. AAP National dues vary depending on Membership type.
Questions? Contact Laura Laskosz, MPH, Section Manager at
firstname.lastname@example.org or 800/433-9016, ext. 4928
or visit the web site at www.aap.org/sections/rheumatology
AAP Section on Rheumatology Newsletter 7
November 13, 2001
The Section on Rheumatology Executive sor to visit a selected site in the 02-03 Meeting, a Pediatric Rheumatology
Committee convened on Tuesday, Novem- academic year. Research Fellowship, and a Debt Interest
ber 13, 2001 in San Francisco, CA. A recruitment campaign will be developed Forgiveness program.
to attract Post-Residency Training Fellows A draft Collaborative Agreement has been
The first Earl J. Brewer Research and James to join the section. In addition, a PRTF will developed by the Section to provide a
Cassidy Awards were presented during the be selected to serve as a non-voting formal acknowledgement of collaboration
American College of Rheumatology member on the Executive Committee. among the AAP, the American College of
Pediatric Rheumatology Other proposed bylaw Rheumatology (ACR), and the Arthritis
Section Business changes include the Foundation of the American Juvenile
Meeting. The first Earl Congratulations! development of a Arthritis Organization (AJAO). The ACR
J. Brewer Research Deborah Kredich, MD referendum to allow one has revised the document and is sending
Award was presented winner of the first of the current members to the AAP and AJAO for signatures.
to Deborah Levy Miller, James T. Cassidy Award of the Executive
MD for her research in and Committee to be The Section is also involved in reviewing
Thromboembolism in Deborah Levy Miller, MD appointed as the Chair- and endorsing the ACR Position Statement
Pediatric Systemic winner of the first Elect. on the Guidelines for Referral, the develop-
Lupus Erythematosus Earl J. Brewer ment of an on-line map of pediatric
(SLE) Patients with Research Award The Section continues rheumatology centers and locations of
Antiphospholipid to move forward on pediatric rheumatologists in the United
Antibodies. Deborah new projects. New States. A public education brochure
Kredich, MD was the projects include a entitled, “What is a Pediatric Rheumatolo-
first recipient of the James T. Cassidy mentoring program, a survey of women in gist” will be available in the near future.
Award for outstanding achievement in pediatric rheumatology, development of
pediatric rheumatology. Plans are under- immunization guidelines for pediatric The next SORh meeting will be held on
way for the Visiting Professorship Award rheumatology, an on-line journal of Sunday, May 5, 2002 in Baltimore, MD.
with anticipation that the visiting profes- pediatric rheumatology, an Annual Fellows
Pediatrician Referral Service (PRS)
the referral service through Medem®’s If you do wish to participate (and we hope
n March 1, 2002, the American
Academy of Pediatrics launched Physician Finder Service at you do!!), in order to make the PRS as
the next evolution of its Pediatri- www.medem.com. accurate and robust as possible, we ask
cian Referral Service (PRS), transforming you to update your contact information,
it into an on-line, searchable service. The PRS is being launched in several board, and sub-board information online
Historically, the Academy has responded phases. In the initial launch, the Members through the AAP Members Only Channel
to approximately 600 to 700 referral Only Channel Directory was transitioned (www.aap.org/moc – click on Member
requests each year. Until recently, these to the PRS with the exception of several Services) or by sending an e-mail to
requests were handled by AAP staff who categories of membership such as Resi- email@example.com, or by calling the Academy at
photocopied and mailed pages from the dents, Honorary Fellows, etc. Phase 2, 888/227-1775. Remember, prospective
Fellowship Directory (Blue Book ). Since which is expected to become operational in patients will use the mailing address and/
the Fellowship Directory was only mid-Spring, will add search capability by or phone number we have on file to
updated once every year or two, the boarded specialty and subspecialty. contact you. Please be sure that the
information was often outdated. Parents information in our records is accurate and
and family members searching for a Participation in the PRS is optional for appropriate for listing in the PRS.
pediatrician, pediatric subspecialist, or AAP members, so if you are no longer in
pediatric surgical specialist, will now have practice, or just prefer not to participate in Thank you for helping us bring this
a more convenient, efficient, and effective this service, you may withdraw your name valuable service to the children and
way to conduct their search. The PRS is from the PRS by visiting www.aap.org/ families we serve.
located at www.aap.org/referral on the referral/prsremove.cfm, calling 888/227-
American Academy of Pediatrics web site. 1775, or e-mailing firstname.lastname@example.org.
Patients and caregivers may also access
AAP Section on Rheumatology Newsletter 8